NZ608560A - Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions - Google Patents
Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositionsInfo
- Publication number
- NZ608560A NZ608560A NZ608560A NZ60856006A NZ608560A NZ 608560 A NZ608560 A NZ 608560A NZ 608560 A NZ608560 A NZ 608560A NZ 60856006 A NZ60856006 A NZ 60856006A NZ 608560 A NZ608560 A NZ 608560A
- Authority
- NZ
- New Zealand
- Prior art keywords
- administering
- compositions
- methods
- growth factor
- nerve growth
- Prior art date
Links
- 201000008482 osteoarthritis Diseases 0.000 title abstract 2
- 229940122467 Nerve growth factor antagonist Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/104,248 US7569364B2 (en) | 2002-12-24 | 2005-04-11 | Anti-NGF antibodies and methods using same |
NZ59533606 | 2006-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ608560A true NZ608560A (en) | 2015-05-29 |
Family
ID=53490938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ608560A NZ608560A (en) | 2005-04-11 | 2006-04-11 | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ608560A (en) |
-
2006
- 2006-04-11 NZ NZ608560A patent/NZ608560A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL239170A0 (en) | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same | |
TW200513468A (en) | Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors | |
EA201290189A1 (en) | HUMAN NEUTRALIZING ANTI-NGF ANTIBODIES AS SELECTIVE INHIBITORS OF METABOLIC WAYS OF NERVES GROWTH FACTOR | |
WO2011014255A8 (en) | Treatment of crohn's disease with laquinimod | |
MY155961A (en) | Chemical compounds 251 | |
TW200806299A (en) | Treatment of pain | |
EA201690994A1 (en) | ACTIVIN-ACTRIIA ANTAGONISTS AND APPLICATION TO STIMULATE BONE GROWTH IN CANCER PATIENTS | |
TW200800976A (en) | New compounds for the treatment of neurological, psychiatric or pain disorders | |
TW200639159A (en) | Treatment of pain | |
SG166093A1 (en) | Inhibitors of brutonæs tyrosine kinase | |
TW200606162A (en) | Pyrazolopyridine derivatives | |
MX2007004955A (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally. | |
EA200971107A1 (en) | CATECHOLAMINE DERIVATIVES, USEFUL FOR THE TREATMENT OF PARKINSON'S Disease | |
DE502005005636D1 (en) | Spirocyclische cyclohexan-derivate | |
MX2013012661A (en) | Bicyclic pyridazine compounds as pim inhibitors. | |
MX2009009133A (en) | Improved medicinal compositions comprising buprenorphine and naloxone. | |
TNSN07263A1 (en) | Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them | |
SE0400184D0 (en) | New therapeutic use | |
RU2013132566A (en) | THERAPEUTIC AGAINST HERNIASIS | |
MX366496B (en) | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use. | |
TNSN08506A1 (en) | Substituted carboxamides | |
DE602004016950D1 (en) | USE OF CYCLIN D1 INGREDIENTS FOR BREAST CANCER TREATMENT | |
MX2008015323A (en) | Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association. | |
NZ608560A (en) | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions | |
WO2007144889A3 (en) | Treatment of neurofibromatosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 11 APR 2016 BY SHELSTON IP Effective date: 20150902 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2017 BY THOMSON REUTERS Effective date: 20160317 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2018 BY THOMSON REUTERS Effective date: 20170322 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2019 BY THOMSON REUTERS Effective date: 20180321 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2020 BY THOMSON REUTERS Effective date: 20190319 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2021 BY THOMSON REUTERS Effective date: 20200317 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2022 BY THOMSON REUTERS Effective date: 20210310 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2023 BY THOMSON REUTERS Effective date: 20220308 |
|
LAPS | Patent lapsed |